The International Diabetes Closed Loop (iDCL) Trial: Clinical Acceptance of the Artificial Pancreas
Public ClinicalTrials.gov record NCT03563313. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Pivotal Study of t:Slim X2 With Control-IQ Technology
Study identification
- NCT ID
- NCT03563313
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Not applicable
- Lead sponsor
- University of Virginia
- Other
- Enrollment
- 168 participants
Conditions and interventions
Conditions
Interventions
- t:slim X2 with Control-IQ Technology & Dexcom G6 CGM Device
- Sensor-augmented pump (SAP) Device
Device
Eligibility (public fields only)
- Age range
- 14 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Jun 27, 2018
- Primary completion
- Apr 7, 2019
- Completion
- Apr 7, 2019
- Last update posted
- Apr 27, 2020
2018 – 2019
United States locations
- U.S. sites
- 7
- U.S. states
- 6
- U.S. cities
- 7
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Sansum Diabetes Research Institute | Santa Barbara | California | 93105 | — |
| Stanford University | Stanford | California | 94304 | — |
| Barbara Davis Center, University of Colorado | Aurora | Colorado | 80045 | — |
| Harvard University (Joslin Diabetes Center) | Boston | Massachusetts | 02215 | — |
| Mayo Clinic | Rochester | Minnesota | 55902 | — |
| Icahn School of Medicine at Mount Sinai | New York | New York | 10029 | — |
| University of Virginia Center for Diabetes Technology | Charlottesville | Virginia | 22903 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT03563313, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Apr 27, 2020 · Synced Jul 22, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT03563313 live on ClinicalTrials.gov.